University of Surrey

Test tubes in the lab Research in the ATI Dance Research

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G , Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, GJM, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H, Watson, Y, Dive, C and Jayson, GC (2013) A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72 (6). pp. 1343-1352.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Horsley, L
Cummings, J
Middleton, M
Ward, T
Backen, A
Clamp, A
Dawson, M
Farmer, H
Fisher, N
Halbert, G
Halford, S
Harris, A
Hasan, J
Hogg, P
Kumaran, G
Little, R
Parker, GJM
Potter, P
Saunders, M
Roberts, C
Shaw, D
Smith, N
Smythe, J
Taylor, Aa.taylor@surrey.ac.uk
Turner, H
Watson, Y
Dive, C
Jayson, GC
Date : 1 December 2013
Identification Number : 10.1007/s00280-013-2320-9
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, Pharmacology & Pharmacy, ONCOLOGY, PHARMACOLOGY & PHARMACY, Phase 1, GSAO, Novel arsenic compound, Clinical trial, DCE-MRI, ACUTE PROMYELOCYTIC LEUKEMIA, APOPTOSIS PROTEIN XIAP, X-LINKED INHIBITOR, ARSENIC TRIOXIDE, CLINICAL-EFFICACY, ANGIOGENESIS INHIBITOR, METABOLISM INHIBITORS, CANCER-THERAPY, CELL-DEATH, VALIDATION
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:02
Last Modified : 17 May 2017 14:46
URI: http://epubs.surrey.ac.uk/id/eprint/826145

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800